Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 9,291,421        
Beginning balance, amount at Dec. 31, 2018 $ 9,291 $ 28,567,221 $ (2,396) $ (21,655,712) $ 6,918,404
Stock-based compensation (non-cash)   233,776     233,776
Net loss (1,376,235) (1,376,235)
Accumulated other comprehensive gain (loss)     (2,127)   (2,127)
Ending balance, shares at Mar. 31, 2019 9,291,421        
Ending balance, amount at Mar. 31, 2019 $ 9,291 28,800,997 (4,523) (23,031,947) 5,773,818
Beginning balance, shares at Dec. 31, 2018 9,291,421        
Beginning balance, amount at Dec. 31, 2018 $ 9,291 28,567,221 (2,396) (21,655,712) 6,918,404
Stock-based compensation (non-cash)         734,365
Net loss         (3,018,015)
Ending balance, shares at Sep. 30, 2019 9,291,421        
Ending balance, amount at Sep. 30, 2019 $ 9,291 29,301,586 (12,195) (24,673,727) 4,624,955
Beginning balance, shares at Mar. 31, 2019 9,291,421        
Beginning balance, amount at Mar. 31, 2019 $ 9,291 28,800,997 (4,523) (23,031,947) 5,773,818
Stock-based compensation (non-cash)   257,633     257,633
Net loss (905,700) (905,700)
Accumulated other comprehensive gain (loss)     1,067   1,067
Ending balance, shares at Jun. 30, 2019 9,291,421        
Ending balance, amount at Jun. 30, 2019 $ 9,291 29,058,630 (3,456) (23,937,647) 5,126,818
Stock-based compensation (non-cash)   242,956     242,956
Net loss (736,080) (736,080)
Accumulated other comprehensive gain (loss)     (8,739)   (8,739)
Ending balance, shares at Sep. 30, 2019 9,291,421        
Ending balance, amount at Sep. 30, 2019 $ 9,291 29,301,586 (12,195) (24,673,727) 4,624,955
Beginning balance, shares at Dec. 31, 2019 10,587,632        
Beginning balance, amount at Dec. 31, 2019 $ 10,587 38,508,825 (10,970) (25,880,586) 12,627,856 [1]
Stock-based compensation (non-cash)   338,497     338,497
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, shares 33,903        
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, amount $ 34 526,109     526,143
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 1,288        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 1 (1)     0
Offering costs   (2,161)     (2,161)
Net loss (1,090,877) (1,090,877)
Accumulated other comprehensive gain (loss)     (4,041)   (4,041)
Ending balance, shares at Mar. 31, 2020 10,622,823        
Ending balance, amount at Mar. 31, 2020 $ 10,622 39,371,269 (15,011) (26,971,463) 12,395,417
Beginning balance, shares at Dec. 31, 2019 10,587,632        
Beginning balance, amount at Dec. 31, 2019 $ 10,587 38,508,825 (10,970) (25,880,586) 12,627,856 [1]
Stock-based compensation (non-cash)         989,568
Net loss         (4,176,125)
Ending balance, shares at Sep. 30, 2020 11,452,177        
Ending balance, amount at Sep. 30, 2020 $ 11,452 47,546,915 (10,044) (30,056,711) 17,491,612
Beginning balance, shares at Mar. 31, 2020 10,622,823        
Beginning balance, amount at Mar. 31, 2020 $ 10,622 39,371,269 (15,011) (26,971,463) 12,395,417
Stock-based compensation (non-cash)   367,358     367,358
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, shares 111,858        
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, amount $ 113 950,577     950,690
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 1,292        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 1 (1)     0
Offering costs   (116,605)     (116,605)
Net loss (1,445,810) (1,445,810)
Accumulated other comprehensive gain (loss)     3,457   3,457
Ending balance, shares at Jun. 30, 2020 10,735,973        
Ending balance, amount at Jun. 30, 2020 $ 10,736 40,572,598 (11,554) (28,417,273) 12,154,507
Stock-based compensation (non-cash)   283,713     283,713
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, shares 714,916        
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, amount $ 715 6,697,743     6,698,458
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 128        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 1 (1)     0
Offering costs   (7,138)     (7,138)
Net loss (1,639,438) (1,639,438)
Accumulated other comprehensive gain (loss)     1,510   1,510
Ending balance, shares at Sep. 30, 2020 11,452,177        
Ending balance, amount at Sep. 30, 2020 $ 11,452 $ 47,546,915 $ (10,044) $ (30,056,711) $ 17,491,612
[1] Derived from the Company's audited consolidated financial statements.